Emmaus Life Correlations
| EMMADelisted Stock | USD 0.26 0.00 0.00% |
The current 90-days correlation between Emmaus Life Sciences and Cell Source is -0.36 (i.e., Very good diversification). The correlation of Emmaus Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Emmaus Life Correlation With Market
Average diversification
The correlation between Emmaus Life Sciences and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Emmaus Life Sciences and DJI in the same portfolio, assuming nothing else is changed.
Emmaus |
The ability to find closely correlated positions to Emmaus Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emmaus Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emmaus Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emmaus Life Sciences to buy it.
Moving together with Emmaus OTC Stock
| 0.64 | ENSCW | Ensysce Biosciences | PairCorr |
| 0.79 | HRGN | Harvard Apparatus | PairCorr |
| 0.66 | ZIVO | Zivo Bioscience | PairCorr |
| 0.63 | KRBP | Kiromic Biopharma | PairCorr |
| 0.65 | LADX | LadRx | PairCorr |
| 0.65 | MRVT | Miravant Medical Tec | PairCorr |
| 0.69 | NEXI | Neximmune | PairCorr |
Moving against Emmaus OTC Stock
| 0.64 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.62 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.56 | VAXX | Vaxxinity | PairCorr |
| 0.35 | EPRX | Eupraxia Pharmaceuticals Downward Rally | PairCorr |
| 0.31 | EVLO | Evelo Biosciences | PairCorr |
| 0.72 | XOMAO | XOMA | PairCorr |
| 0.71 | XOMAP | XOMA Corp | PairCorr |
| 0.6 | ODTC | Odonate Therapeutics | PairCorr |
| 0.49 | OKUR | OnKure Therapeutics, Symbol Change | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Emmaus OTC Stock performing well and Emmaus Life OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Emmaus Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NRXPW | 11.67 | 0.78 | 0.03 | (0.35) | 15.83 | 27.27 | 100.20 | |||
| KLDO | 152.17 | 81.60 | 0.00 | (2.02) | 0.00 | 50.00 | 4,849 | |||
| SCPS | 11.67 | 0.05 | 0.01 | 0.11 | 16.06 | 33.33 | 94.02 | |||
| CLCS | 9.32 | 2.21 | 0.12 | (0.42) | 10.05 | 45.24 | 92.05 | |||
| ATRX | 7.96 | 0.57 | 0.02 | 10.14 | 11.37 | 20.00 | 77.97 | |||
| PTE | 9.13 | (2.07) | 0.00 | (1.26) | 0.00 | 16.82 | 82.60 | |||
| ZIVO | 3.01 | (0.62) | 0.00 | 2.05 | 0.00 | 5.31 | 36.36 | |||
| ANEB | 5.26 | 0.02 | 0.00 | 0.06 | 0.00 | 8.85 | 76.00 |
Emmaus Life Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Emmaus Life otc stock to make a market-neutral strategy. Peer analysis of Emmaus Life could also be used in its relative valuation, which is a method of valuing Emmaus Life by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Emmaus Life Corporate Management
Elected by the shareholders, the Emmaus Life's board of directors comprises two types of representatives: Emmaus Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emmaus. The board's role is to monitor Emmaus Life's management team and ensure that shareholders' interests are well served. Emmaus Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emmaus Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| MS MBA | Consultant | Profile | |
| Steven Lee | Independent Consultant | Profile | |
| Dale JD | G Counsel | Profile | |
| George Sekulich | VP Officer | Profile | |
| PharmD PharmD | Clinical, Affairs | Profile | |
| MD MPH | Chairman CEO | Profile |
Still Interested in Emmaus Life Sciences?
Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.